Guenther Mueller‐Velten

Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate‐P^®)

Arthur R. Thompson, Joan Cox Gill, Bruce M. Ewenstein et al. · Haemophilia · 2004 · 109 citations

Medicine, Pharmacotherapy, Surgery +15

Pharmacokinetic analysis of plasma‐derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B

Bruce M. Ewenstein, J. Heinrich Joist, Amy D. Shapiro et al. · Transfusion · 2002 · 100 citations

Medicine, Hematology, Pharmacokinetics +16

Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure

Joanne Simpson, Pardeep S. Jhund, Lars H. Lund et al. · JAMA Cardiology · 2020 · 99 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Effect of Sacubitril/Valsartan on Recurrent Events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure trial (PARADIGM-HF)

Ulrik M. Mogensen, Jianjian Gong, Pardeep S. Jhund et al. · European Journal of Heart Failure · 2018 · 80 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate‐P^®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy

Joan Cox Gill, Bruce M. Ewenstein, Arthur R. Thompson et al. · Haemophilia · 2003 · 73 citations

Medicine, Hematology, Surgery +17